Personalized Therapy of Molecular Tumor Board Participation With the Guidance of Next Generation Sequencing

Clinical trial NCT03929653 · UNKNOWN

Trial details

NCT number: NCT03929653
Sponsor: Tianjin Medical University Second Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Solid Tumor, Adult

Start date: 2017-06-01
Primary completion: 2019-06-30
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.